Bibliografía del artículo
1. Pickering TG, James GD, Boddie C, Harshfield GA, Blank, S Laragh JH. How common is white coat hypertension?. JAMA 259:225-228, 1988.
2. 2007 Guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25:1105-1187, 2007.
3. Bayó J, Cos FX, Roca C, Dalfó A, Martín-Baranera MM, Albert B. Home blood pressure self-monitoring: diagnostic performance in white-coat hypertension. Blood Press Monit. 11:47-52, 2006.
4. Vinyoles E, de la Figuera M. Características clínicas del hipertenso de bata blanca. Med Clín (Barc) 105:287-291, 1995.
5. Verdecchia P, Schillaci G, Boldrini F, Zampi I, Porcellani C. Variability between current definitions of "normal" ambulatory blood pressure. Implications in the assessment of white coat hypertension. Hypertension 20:555-562, 1992.
6. Dolan E, Stanton A, Atkins N, Den Hond E, Thijs L, McCormack P, Staessen J, et al. Determinants of white-coat hypertension. Blood Press Monit 9:307-309, 2004.
7. Angeli F, Verdecchia P, Gattobigio R, Sardone M , Reboldi G. White-coat hypertension in adults. Blood Press Monit 10:301-309, 2005.
8. Staessen J, O'Brien E, Atkins N, Amery A. Short report: ambulatory blood pressure in normotensive compared with hypertensive subjects. J Hypertens 11:1289-1297, 1993.
9. Vinyoles E, Felip A, Pujol E, de la Sierra A, Durà R, Hernández del Rey R et al. Clinical characteristics of isolated clinic hypertension. J Hypertens 26:438-445, 2008.
10. Cuspidi C, Meani S, Sala C, Valerio C, Fusi V , Zanchetti A et al. How reliable is isolated clinical hypertension defined by a single 24-h ambulatory blood pressure monitoring? J Hypertens 25:315-320, 2007.
11. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 370:1219-1229, 2007.
12. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML et al. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 51:55-61, 2008.
13. Conen D, Bamberg F. Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis. J Hypertens 26:1290-1299, 2008.
14. Banegas JR, Segura J, Sobrino J, Rodríguez-Artalejo F, de la Sierra A, Cruz JJ, et al. Effectiveness of blood pressure control outside the medical setting. Hypertension 49:62-68, 2007.
15. Vinyoles E, Rodríguez-Blanco T, de la Sierra A, Felip A, Banegas JR, de la Cruz JJ, et al. Isolated clinic hypertension: diagnostic criteria based on 24-h blood pressure definition. J Hypertens 28:2407-2413, 2010.
16. NICE Clinical Guidelines 2011. Disponible en: www.nice.org.uk/guidance/CG127. Consultado Octubre, 2011.
17. Hozawa A, Ohkubo T, Obara T, Metoki H, Kikuya M, Asayama K, et al. Introversion associated with large differences between screening blood pressure and home blood pressure measurement: the Ohasama study. J Hypertens 24:2183-2189, 2006.
18. Pickering TG. Should white coat hypertension be treated? J Clin Hypertens (Greenwich) 7:550-553, 2005.
19. Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications Hypertension 35:844-851, 2000.
20. Dawes MG, Bartlett G, Coats AJ, Juszczak E. Comparing the effects of white coat hypertension and sustained hypertension on mortality in a UK primary care setting. Ann Fam Med 6:390-396, 2008.
21. Ben-Dov IZ, Kark JD, Mekler J, Shaked E, Bursztyn M. The white coat phenomenon is benign in referred treated patients: a 14-year ambulatory blood pressure mortality study. J Hypertens 26:699-705, 2008.
22. Fagard RH, Cornelissen VA.. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens 25:2193-2198, 2007.
23. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta-analysis. Am J Hypertens 24:52-58, 2011.
24. Márquez E, Casado JJ, Fernández A, Botello I. ¿La hipertensión de bata blanca es un estadio prehipertensivo? Dos años de seguimiento mediante monitorización ambulatoria de la presión arterial. Hipertensión 20(9):388-394, 2003.
25. Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Friz HP et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension 54:226-232, 2009.
26. Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, et al. Short-and long-term incidence of stroke in white-coat hypertension. Hypertension 45:203-208, 2005.
27. Kotsis V, Stabouli S, Toumanidis S, Papamichael C, Lekakis J, Germanidis G, et al. Target organ damage in "white coat hypertension" and "masked hypertension". Am J Hypertens 21:393-399, 2008.
28. de Simone G, Schillaci G, Chinali M, Angeli F, Reboldi GP, Verdecchia P. Estimate of white-coat effect and arterial stiffness. J Hypertens 25:827-831, 2007.
29. Puato M, Palatini P, Zanardo M, Dorigatti F, Tirrito C, Rattazzi M, et al. Increase in carotid intima-media thickness in grade I hypertensive subjects: white-coat versus sustained hypertension. Hypertension 51:1300-1305, 2008.
30. Puchades R, Ruiz-Nodar JM, Blanco F, Rodríguez F, Gabriel R, Suárez C. White-coat hypertension in the elderly. Echocardiographic analysis. A substudy of the EPICARDIAN project. Rev Esp Cardiol 63:1377-1381, 2010.
31. Mulè G, Nardi E, Cottone S, Cusimano P, Incalcaterra F, Palermo A, et al. Metabolic syndrome in subjects with white-coat hypertension: impact on left ventricular structure and function. J Hum Hypertens 21:854-860, 2007.
32. Wimmer NJ, Sathi K, Chen TL, Townsend RR, Cohen DL. Comparison of pulse wave analysis between persons with white coat hypertension and normotensive persons. J Clin Hypertens (Greenwich) 9:513-517, 2007.
33. Kanno A, Metoki H, Kikuya M, Terawaki H, Hara A, Hashimoto T, et al. Usefulness of assessing masked and white-coat hypertension by ambulatory blood pressure monitoring for determining prevalent risk of chronic kidney disease: the Ohasama study. Hypertens Res 33:1192-1198, 2010.
34. Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Grassi G, et al. Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension. J Hypertens 27:1672-1678, 2009.
35. Helvaci MR, Kaya H, Duru M, Yalcin A. What is the relationship between white coat hypertension and dyslipidemia? Int Heart J 49:87-93, 2008.
36. Vinyoles E, Garaikoetxea M, Ibernón S, Sancho B, Díaz B, de la Figuera M. Decisiones y actitudes terapéuticas en los pacientes con hipertensión clínica aislada. Rev Clin Esp 201:174-178, 2001.